Dr. Lu’s research involves the use of nanoparticle-based formulations to deliver therapeutic and diagnostic agents. These are primarily applied in the diagnosis and treatment of cancer. The main projects are:
- Bioresponsive theranostic nanovectors for improving drug therapeutic ratios
- Neutron-activatable nanoparticles for targeted radionuclide therapy of tumors
- Quercetin nanoemulsions for enhancing its oral bioavailability and chemoprotective effect